会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 83. 发明公开
    • Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists
    • 邻位取代的含有3(杂)芳基环,它们的制备以及它们作为前列腺素E2(PGE2)拮抗剂的用途的芳族化合物
    • EP0752421A1
    • 1997-01-08
    • EP96304888.9
    • 1996-07-02
    • ZENECA LIMITED
    • Breault, Gloria AnneOldfield, JohnTucker, HowardWarner, Peter
    • C07D213/40C07D213/55C07D213/74C07D213/75A61K31/44C07D233/54A61K31/415C07D237/24A61K31/50C07C63/04C07C63/64A61K31/19C07C65/05C07C65/21C07C229/38C07C229/52C07C229/60C07C233/65C07C233/69C07C237/30C07C237/32C07C323/32C07C323/62
    • C07D213/75C07C63/331C07C65/105C07C65/24C07C229/38C07C229/52C07C229/60C07C233/65C07C233/69C07C237/30C07C237/32C07C323/62C07D213/55C07D213/80C07D233/64C07D237/24
    • The invention relates to compounds of the formula
      wherein:

      A is an optionally substituted ring system provided that the -Z-B-R 1 and -X-D linking groups are positioned in a 1,2 relationship to one another on ring carbon atoms and the ring atom positioned ortho to the -X- linking group (and therefore in the 3-position relative to the -Z- linking group) is not substituted;
      B is an optionally substituted ring system
      D is optionally substituted: pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, pyrrolyl, thienyl, furyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl or phenyl;
      R 1 is positioned on ring B in a 1,3 or 1,4 relationship with the -Z- linking group in 6-membered rings and in a 1,3-relationship with the -Z- linking group in 5-membered rings and is as defined in the description;
      X is -OCH 2- , -SCH 2- , -CH 2 CH 2- , CH 2- , -O-, -S- or -N(R 4 )CH 2- wherein the left hand atom is attached to A and the right hand atom is attached to D;
      Z is of the formula -CH(R 3 )CH(R 3 )N(R 2 )-, -N(R 2 )CH(R 3 )-, -CH(R 3 )P 1 -, -(CH(R 3 ))m- or -CH(R 3 )N(R 2 )-
         wherein
      R 2 is hydrogen, C 1-6 alkyl (optionally substituted by hydroxy, cyano, nitro, amino, halo, C 1-4 alkanoyl, C 1-4 alkoxy or trifluoromethyl) C 2-6 alkenyl, C 2-6 alkynyl, C 3-6 cycloalkyl, C 3-6 cycloalkylC 1-3 alkyl, C 3-6 cycloalkylC 2-3 alkenyl, C 5-6 cycloalkenyl, C 5-6 cycloalkenylC 1-3 alkyl, C 5-6 cycloalkenylC 2-3 alkenyl, phenyl, phenylC 1-3 alkyl or 5- or 6-membered heteroarylC 1-3 alkyl;
      R 3 is hydrogen or C 1-4 alkyl;
      P 1 is oxygen or sulphur, m is 2 or 3 and R 4 is hydrogen or C 1-4 alkyl and wherein the left hand atom is attached to A and the right hand atom is attached to B; provided that when Z is -CH(R 3 )N(R 2 )- or -(CH(R 3 ))m-, X is not -OCH 2 -; and N-oxides of -NR 2 where chemically possible;
      and S-oxides of sulphur containing rings where chemically possible;
      and pharmaceutically acceptable salts and in vivo hydrolysable esters and amides thereof.

      Processes for their preparation, intermediates in their preparation, their use as pharmaceutical agents and pharmaceutical compositions containing them.
      The compounds of the invention are useful in the treatment of pain such as the pain associated with joint conditions (such as rheumatoid arthritis and osteoarthritis), postoperative pain, post-partum pain, the pain associated with dental conditions (such as dental caries and gingivitis), the pain associated with burns (including sunburn), the treatment of bone disorders (such as osteoporosis, hypercalcaemia of malignancy and Paget's disease), the pain associated with sports injuries and sprains and all other painful conditions in which E-type prostaglandins wholly or in part play a pathophysiological role.
    • 本发明涉及下式的化合物 worin:A是任选substituiertem环系统提供DASS死-ZBR <1>和-Xd连接基团在1,2关系彼此在环碳原子和被定位 环原子邻位的-X-的连接基团(并且相对于-Z-连接基团的3位在THEREFORE)不substituiertem; B是任选substituiertem环系统D是任选substituiertem:吡啶基,吡嗪基,嘧啶基,哒嗪基,吡咯基,噻吩基,呋喃基,咪唑基,吡唑基,噻唑基,异噻唑基,恶唑基,异恶唑基或苯基; [R <1>与-Z-连接基团1,3-或1,4-关系在5元被定位在环B在6元环,而在与所述-Z-连接基团1,3-关系 环和是如说明书中所定义; X是-OCH 2,-SCH 2,-CH 2 CH 2,CH 2,-O - , - S-或-N(R <4>)CH2 worin左手原子连接于A和右手原子是 附着到D; Z为式CH(R <3>)CH(R <3>)N(R <2>) - , - N(R <2>)CH(R <3>) - , - CH(R <3>)P <1> - , - (CH(R <3>))m-或-CH(R <3>)N(R <2>) - 氢worinř<2>是,C 1-6烷基 (任选地被羟基,氰基,硝基,氨基,卤素,C1-4alkanoyl,C 1-4烷氧基或三氟甲基substituiertem)C 2-6烯基,C 2-6炔基,C 3-6环烷基,C3-6cycloalkylC1-3alkyl,C3-6cycloalkylC2-3alkenyl,C5- 6cycloalkenyl,C5-6cycloalkenylC1-3alkyl,C5-6cycloalkenylC2-3alkenyl,苯基,phenylC1-3alkyl或5-或6-元heteroarylC1-3alkyl; [R <3>是氢或C 1-4烷基; P <1>为氧或硫,m是2或3,R <4>是氢或C 1-4烷基和worin左手原子连接于A和右手原子连接到B; 提供确实当Z是-CH(R <3>)N(R <2>) - 或 - (CH(R <3>))间 - 时,X不是-OCH 2; 和-NR <2>的N-氧化物在化学上可能; 和含硫环的S-氧化物在化学上可能; 和药学上可接受的盐和体内可水解的酯和酰胺。 它们的制备方法,其制备中间体,其作为药物和含有它们的药物组合物。 本发明的化合物可用于治疗疼痛的有用:如与关节条件(颜色:如类风湿性关节炎和骨关节炎)相关的疼痛,手术后疼痛,产后疼痛,与牙齿条件(颜色相关的疼痛:如龋齿和牙龈炎 ),烧伤(包括晒伤相关的疼痛),骨疾病(治疗:如骨质疏松症,恶性高血钙和Paget氏病),与运动损伤和扭伤和其中E型前列腺素全所有其它疼痛病症相关的疼痛 或部分发挥病理生理作用。
    • 88. 发明公开
    • Fungicides for the control of take-all disease of plants
    • Fungizidefürdie Kontrolle der Wurzelerkrankung von Pflanzen。
    • EP0538231A1
    • 1993-04-21
    • EP92870168.9
    • 1992-10-16
    • MONSANTO COMPANY
    • Phillion, Dennis PaulBraccolino, Diane SusanGraneto, Matthew JamesPhillips, Wendell GaryVan Sant, Karey AlanWalker, Daniel MarkWong, Sai Chi
    • A01N55/00A01N37/18A01N55/02A01N37/40C07F7/08C07F7/22C07F7/30C07C233/65C07C317/44A01N55/04A01N37/44C07C235/60C07C323/62C07C233/69C07C237/30C07C233/66
    • C07C317/44A01N37/18A01N37/26A01N37/40A01N37/44A01N41/10A01N55/00A01N55/02A01N55/04C07C233/65C07C233/66C07C233/69C07C235/60C07C237/30C07C323/60C07C2601/04C07C2601/08C07F7/0812C07F7/0814C07F7/0818C07F7/2212C07F7/30C07F15/025
    • A method of controlling Take-all disease of plants by applying, preferably to the seed prior to planting, a fungicide of the formula

         wherein Z₁ and Z₂ are C or N and are part of an aromatic ring selected from benzene, pyridine, thiophene, furan, pyrrole, pyrazole, thiazole, and isothiazole;
         A is selected from -C(X)-amine, -C(O)-SR₃, -NH-C(X)R₄, and -C(=NR₃)-XR₇;
         B is -W m -Q(R₂)₃ or selected from o-tolyl, 1-naphthyl, 2-naphthyl, and 9-phenanthryl, each optionally substituted with halogen or R₄;
         Q is C, Si, Ge, or Sn;
         W is -C(R₃) p H (2-p) -; or when Q is C, W is selected from -C(R₃) p H (2-p) -, -N(R₃) m H (1-m) -, -S(O) p -, and -O-;
         X is O or S;
         n is 0, 1, 2, or 3;
         m is 0 or 1;
         p is 0, 1, or 2;
         each R is independently selected from

      a) halo, formyl, cyano, amino, nitro, thiocyanato, isothiocyanato, trimethylsilyl, and hydroxy;
      b) C1-C4 alkyl, alkenyl, alkynyl, C3-C6 cycloalkyl, and cycloalkenyl, each optionally substituted with halo, hydroxy, thio, amino, nitro, cyano, formyl, phenyl, C1-C4 alkoxy, alkylcarbonyl, alkylthio, alkylamino, dialkylamino, alkoxycarbonyl, (alkylthio)carbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylsulfinyl, or alkylsulfonyl;
      c) phenyl, furyl, thienyl, pyrrolyl, each optionally substituted with halo, formyl, cyano, amino, nitro, C1-C4 alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylamino, dialkylamino, haloalkyl, and haloalkenyl;
      d) C1-C4 alkoxy, alkenoxy, alkynoxy, C3-C6 cycloalkyloxy, cycloalkenyloxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, dialkylamino, alkylcarbonylamino, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylcarbonyl, alkylcarbonyloxy, alkoxycarbonyl, (alkylthio)carbonyl, phenylcarbonylamino, phenylamino, each optionally substituted with halo;
         wherein two R groups may be combined to form a fused ring;
      each R₂ is independently selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl and phenyl, each optionally substituted with R₄ or halogen; and wherein, when Q is C, R₂ may also be selected from halo, alkoxy, alkylthio, alkylamino, and dialkylamino;
         wherein two R₂ groups may be combined to form a cyclo group with Q;
         R₃ is C1-C4 alkyl;
         R₄ is C1-C4 alkyl, haloalkyl, alkoxy, alkylthio, alkylamino, or dialkylamino; and
         R₇ is C1-C4 alkyl, haloalkyl, or phenyl, optionally substituted with halo, nitro, or R₄;
         or an agronomic salt thereof.
    • 一种通过在种植之前优选施用式(CHEM)的杀真菌剂,其中Z 5和Z 6为C或N并且是芳环的一部分的方法来控制植物的所有疾病的方法 选自苯,吡啶,噻吩,呋喃,吡咯,吡唑,噻唑和异噻唑; A选自-C(X) - 胺,-C(O)-SR 7,-NH-C(X)R 8和-C(= NR 7)-XR1 / 2; B是-Wm-Q(R 6)7或选自邻甲苯基,1-萘基,2-萘基和9-菲基,各自任选被卤素或R 8取代; Q是C,Si,Ge或Sn; W是-C(R 7)pH(2-p) - ; 或当Q为C时,W选自-C(R 7)pH(2-p) - , - N(R 7)m H(1-m) - , - S(O) 和-O-; X为O或S; n为0,1,2或3; m为0或1; p为0,1或2; 每个R独立地选自a)卤素,甲酰基,氰基,氨基,硝基,氰硫基,异硫氰酸根,三甲基甲硅烷基和羟基; 羟基,硫代,氨基,硝基,氰基,甲酰基,苯基,C 1 -C 4烷氧基,烷基羰基,烷硫基,烷氨基,C 1 -C 4烷基, 二烷基氨基,烷氧基羰基,(烷硫基)羰基,烷基氨基羰基,二烷基氨基羰基,烷基亚磺酰基或烷基磺酰基; C)苯基,呋喃基,噻吩基,吡咯基,各自任选被卤素,甲酰基,氰基,氨基,硝基,C 1 -C 4烷基,烯基,炔基,烷氧基,烷硫基,烷基氨基,二烷基氨基,卤代烷基和卤代烯基取代。 d)C 1 -C 4烷氧基,烯氧基,炔氧基,C 3 -C 6环烷氧基,环烯氧基,烷硫基,烷基亚磺酰基,烷基磺酰基,烷基氨基,二烷基氨基,烷基羰基氨基,氨基羰基,烷基氨基羰基,二烷基氨基羰基,烷基羰基,烷基羰基氧基,烷氧基羰基,(烷硫基)羰基,苯基羰基氨基,苯基氨基 ,各自任选被卤素取代; 其中两个R基团可以组合形成稠环; 每个R 6独立地选自烷基,烯基,炔基,环烷基,环烯基和苯基,各自任选被R 8或卤素取代; 并且其中当Q为C时,R 6也可以选自卤素,烷氧基,烷硫基,烷基氨基和二烷基氨基; 其中两个R 6基团可以与Q结合形成环基团; R 7是C 1 -C 4烷基; R 8是C 1 -C 4烷基,卤代烷基,烷氧基,烷硫基,烷基氨基或二烷基氨基; R 1/2是任选被卤素,硝基或R 8取代的C 1 -C 4烷基,卤代烷基或苯基; 或其农艺盐。 升